"Bryn Mawr Hospital, a nationally recognized community teaching hospital, is conveniently located on the Main Line, just outside of Philadelphia."

During the past decade, Bryn Mawr Hospital conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 100 clinical trials were completed, i.e. on average, 138.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 37 clinical trials were completed. i.e. 194.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bryn Mawr Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 78 trials, followed by "Radiation Therapy Oncology Group" with 33 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bryn Mawr Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "NRG Oncology" with 40 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Bryn Mawr Hospital" are "Breast Cancer" (20 trials), "Lung Cancer" (12 trials), "Colorectal Cancer" (9 trials), "Invasive Breast Carcinoma" (9 trials) and "Prostate Cancer" (9 trials). Many other conditions were trialed in "Bryn Mawr Hospital" in a lesser frequency.

Most popular intervention types in "Bryn Mawr Hospital" are "Drug" (175 trials), "Other" (110 trials), "Biological" (74 trials), "Radiation" (58 trials) and "Procedure" (51 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (43 trials), "Paclitaxel" (28 trials), "Questionnaire Administration" (27 trials) and "Carboplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "Bryn Mawr Hospital" are 169 trials for "All" genders, 53 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Bryn Mawr Hospital". undefined are not yet recruiting, 28 are recruiting, 73 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 109 completed trials in Bryn Mawr Hospital, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Bryn Mawr Hospital, 4 "Phase 1" clinical trials were conducted, 95 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".

Bryn Mawr Hospital has several departments that took part in Clinical trials: "Cancer Center of Paoli Memorial Hospital" - 51 trials, "Main Line Health NCORP" - 38 trials, "Main Line Health Heart Center" - 14 trials, "Bryn Mawr Rehabilitation Hospital" - 2 trials